Diseases, Conditions, Syndromes

FDA issues EUA to baricitinib plus remdesivir for COVID-19

(HealthDay)—Emergency use authorization was issued for baricitinib in combination with remdesivir for hospitalized patients with COVID-19, the U.S. Food and Drug Administration announced Thursday.

Medications

Fluvoxamine may prevent serious illness in COVID-19 patients

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine ...

Diseases, Conditions, Syndromes

NIH launches trial of antibody drugs against COVID-19

(HealthDay)—A study to assess whether certain approved or experimental drugs are effective against COVID-19 and warrant testing in large clinical trials has been launched by the U.S. National Institutes of Health (NIH).

Obstetrics & gynaecology

COVID-19 can be transmitted in the womb, study reports

A baby girl in Texas—born prematurely to a mother with COVID-19—is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, ...

Medications

Cheap drug is first shown to improve COVID-19 survival

Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid reduced deaths by up to one third in severely ill hospitalized patients.

Medications

Five-day course of remdesivir beneficial in severe COVID-19

(HealthDay)—There seems to be no significant difference between a five- and 10-day course of remdesivir for patients with severe COVID-19 not requiring mechanical ventilation, according to a study published online May 27 ...

page 1 from 6